These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3681367)

  • 1. Detection of estrogen receptor in bone marrow from patients with metastatic breast cancer.
    Berger U; Mansi JL; Wilson P; Coombes RC
    J Clin Oncol; 1987 Nov; 5(11):1779-82. PubMed ID: 3681367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
    Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
    Alberts SR; Ingle JN; Roche PR; Cha SS; Wold LE; Farr GH; Krook JE; Wieand HS
    Cancer; 1996 Aug; 78(4):764-72. PubMed ID: 8756370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
    Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M
    Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
    Masood S
    Arch Pathol Lab Med; 1989 Jan; 113(1):26-30. PubMed ID: 2462858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor determination in percutaneous bone marrow biopsies of patients with metastatic breast cancer.
    Wortman JE; Rundles RW; Moore JO; McCarty KS; McCarty KS
    Med Pediatr Oncol; 1979; 7(3):277-83. PubMed ID: 542192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
    Kiang DT; Kollander R
    J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated immunohistochemical assay for estrogen receptor status in breast cancer using monoclonal antibody CC4-5 on the Ventana ES.
    Nichols GE; Frierson HF; Boyd JC; Hanigan MH
    Am J Clin Pathol; 1996 Sep; 106(3):332-8. PubMed ID: 8816590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunocytochemical staining of estrogen receptor in conventional formalin-fixed paraffin sections in human breast cancer].
    Kawakami S; Kojima O; Uehara Y; Takahashi T
    Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):102-7. PubMed ID: 2468075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.
    McClelland RA; Berger U; Miller LS; Powles TJ; Coombes RC
    J Clin Oncol; 1986 Aug; 4(8):1171-6. PubMed ID: 2426418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies of estrogen receptor determinations by enzyme immuno-assay using the monoclonal antibody, dextran-coated charcoal, and sucrose density gradient methods].
    Tominaga T; Yoshida Y; Kitamura M; Kosaki G
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1782-6. PubMed ID: 2412495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.
    Kommoss F; Pfisterer J; Idris T; Giese E; Sauerbrei W; Schäfer W; Thome M; Pfleiderer A
    Anal Quant Cytol Histol; 1994 Jun; 16(3):203-10. PubMed ID: 7916848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran coated charcoal (DCC) assay and immunocytochemical assay].
    Ozaki T
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):361-6. PubMed ID: 1371912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
    Thorpe SM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of estrogen receptor detection using archival Papanicolaou-stained smears.
    Koyatsu J; Ishi K; Suzuki F; Saito A; Kina K; Okazaki T
    Acta Cytol; 1999; 43(5):825-30. PubMed ID: 10518137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor profile of patients with breast cancer metastatic to bone marrow.
    Budd GT
    J Surg Oncol; 1983 Nov; 24(3):167-9. PubMed ID: 6632904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients.
    Ditsch N; Mayer B; Rolle M; Untch M; Schildberg FW; Funke I
    Recent Results Cancer Res; 2003; 162():141-7. PubMed ID: 12790328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of estrophilin in frozen sections of breast cancers using an estrogen receptor immunocytochemical assay.
    Ozzello L; De Rosa CM; Konrath JG; Yeager JL; Miller LS
    Cancer Res; 1986 Aug; 46(8 Suppl):4303s-4307s. PubMed ID: 2425948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.
    Pertschuk LP; Feldman JG; Kim YD; Braithwaite L; Schneider F; Braverman AS; Axiotis C
    Cancer; 1996 Jun; 77(12):2514-9. PubMed ID: 8640700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.